Indrayani Biotech

Indrayani Biotech Net Debt/Equity

The Net Debt to Equity Ratio of Indrayani Biotech (526445.BO) as of Oct 21, 2026 is 1.89. In the previous year, Net Debt to Equity Ratio was 1.67 — a change of 13.26% (higher).

Net Debt/Equity

1.89

YoY

13.26%

Last updated:

Net Debt to Equity Ratio of Indrayani Biotech is 2025 1.89 . Net Debt to Equity Ratio of Indrayani Biotech was 2024 1.67 . It decreases by 13.26% higher compared to the previous year.

The Indrayani Biotech Net Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/Equity
Date
Net Debt/Equity
Jan 1, 2021
0.75 INR
Jan 1, 2022
0.72 INR
Jan 1, 2023
1.10 INR
Jan 1, 2024
1.67 INR
Jan 1, 2025
1.89 INR
The Indrayani Biotech Net Debt/Equity history
YEARNet Debt/EquityYoY
1.89+13.26%
1.67+51.47%
1.10+53.66%
0.72-5.02%
0.75—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indrayani Biotech Stock analysis

What does Indrayani Biotech do? Indrayani Biotech Ltd generates revenue through its diverse operational divisions, with the Food & Hospitality division supplying food services on a contract basis to colleges and universities, hospitals and healthcare institutions, corporate offices, industries, and information technology companies. The Engineering division contributes by offering solutions for design, development, manufacture, maintenance, and services in power electronics. The Healthcare division serves patients through single specialty clinics and hospitals, as well as outsourced single specialty departments within multi-specialty hospitals. Additionally, the Infrastructure division engages in real estate and infrastructure development. The Agri division markets and sells products such as organic milk, edible oil, vermi compost, and panchakavya, while the Biotech division focuses on marketing and selling microorganism-based bio fertilizer and bio control. These combined activities allow the Chennai-based company to serve a wide range of clients across engineering, food supply, healthcare, infrastructure, agriculture, and biotechnology sectors. Indrayani Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indrayani Biotech stock

Net Debt to Equity Ratio of Indrayani Biotech is 1.89 in 2025.

Net Debt to Equity Ratio of Indrayani Biotech changed from 1.67 to 1.89, representing a 13.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio Indrayani Biotech since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's Indrayani Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Indrayani Biotech

All Key Metrics — Indrayani Biotech